Increasing unusual put option volume: ASTR BIIB
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq touch new peaks as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Nasdaq notches record high close as investors focus on earnings
- Emera and Canadian Utilities agree to merge in $72B all-share deal
Yearly Drug Price Changes by Biogen (BIIB), Gilead (GILD), Regeneron (REGN) and Vertex (VRTX) - Truist
January 3, 2022 5:39 AM ESTTruist analyst Robyn Karnauskas recaps recently announced drug price changes by Biogen (NASDAQ: BIIB), Regeneron (NASDAQ: REGN), Vertex Pharma (NASDAQ: VRTX), and Gilead Sciences (NASDAQ:... More



